Micurx Pharmaceuticals Inc. discovers and develops novel antibiotics to combat drug-resistant bacterial infections. The Company offers a pipeline of discovery and development programs for the treatment of Gram-positive bacteria, Gram-negative bacteria and fungal infections. Micurx Pharmaceuticals operates and markets to customers in the United States and China.